Prospective,randomized,controlled clinical trial of Bryan cervical disc arthroplasty in treatment of single-level cervical spondylosis

XIAO Song-hua,WANG Yan,WANG Zheng,LU Ning,CAI Bin,ZHANG Xue-song
DOI: https://doi.org/10.3969/j.issn.1672-2957.2011.05.003
2011-01-01
Journal of Spinal Surgery
Abstract:Objective To prospectively compare the clinical outcomes of Bryan artificial cervical disc replacement with anterior cervical decompression and fusion(ACDF) in treating single-level cervical spondylotic myelopathy(CSM) or radiculopathy.Methods From August 2006 to February 2009,59 consecutive patients with single-level CSM or radiculopathy were randomly assigned to receive a treatment with Bryan artificial cervical disc replacement(n=27) or ACDF(n=32).Operation time,blood loss and hospital stay were compared between the 2 groups.Range of motion(ROM) of index level and the whole cervical spine were measured on dynamic radiographs.Visual analog scale(VAS) for neck and arm pain,neck disability index(NDI),and radiological measurement were accessed within 2 groups at 6 weeks,and 3,6,12 and 24 months after surgery,respectively.Results There were no statistically significant differences in operation time,blood loss and hospital stay between the 2 groups(P>0.05).VAS for neck and arm pain and NDI were statistically significantly different between 2 groups at 6 weeks and 3 months postoperatively(P<0.05),and not at other time points(P>0.05).However,all the data were significantly different from those before surgery in both groups(P<0.05).ROM of index level was maintained in normal range in Bryan group and had no change in ACDF group.Compared with preoperative motion,ROM of the whole cervical spine was not significantly changed at all the time points in Bryan group(P>0.05),but was significantly different at 6 weeks and 3 months after surgery in ACDF group(P<0.05),which returned to normal gradually in 6 months postoperatively and later.Conclusion This mid-term follow-up indicates that Bryan artificial cervical disc replacement maintains normal ROM of index level,and obtains similar therapeutic effect with that of ACDF.What's more,Bryan replacement is superior to ACDF in regard to short-term clinical outcomes.
What problem does this paper attempt to address?